CN101878426A - 多个待测物诊断输出 - Google Patents

多个待测物诊断输出 Download PDF

Info

Publication number
CN101878426A
CN101878426A CN2008801132886A CN200880113288A CN101878426A CN 101878426 A CN101878426 A CN 101878426A CN 2008801132886 A CN2008801132886 A CN 2008801132886A CN 200880113288 A CN200880113288 A CN 200880113288A CN 101878426 A CN101878426 A CN 101878426A
Authority
CN
China
Prior art keywords
biomarkers
biomarker
patient
diagnostic
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2008801132886A
Other languages
English (en)
Chinese (zh)
Inventor
安东尼·舒伯尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Predictive Biosciences Corp
Original Assignee
Predictive Biosciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Predictive Biosciences Corp filed Critical Predictive Biosciences Corp
Publication of CN101878426A publication Critical patent/CN101878426A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN2008801132886A 2007-09-14 2008-09-12 多个待测物诊断输出 Pending CN101878426A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US97250707P 2007-09-14 2007-09-14
US60/972,507 2007-09-14
US12/034,698 2008-02-21
US12/034,698 US20090075266A1 (en) 2007-09-14 2008-02-21 Multiple analyte diagnostic readout
PCT/US2008/076193 WO2009036288A1 (en) 2007-09-14 2008-09-12 Multiple analyte diagnostic readout

Publications (1)

Publication Number Publication Date
CN101878426A true CN101878426A (zh) 2010-11-03

Family

ID=40452512

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008801132886A Pending CN101878426A (zh) 2007-09-14 2008-09-12 多个待测物诊断输出

Country Status (6)

Country Link
US (1) US20090075266A1 (enExample)
EP (1) EP2198295A4 (enExample)
JP (1) JP2010539490A (enExample)
CN (1) CN101878426A (enExample)
CA (1) CA2698859A1 (enExample)
WO (1) WO2009036288A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108700600A (zh) * 2016-03-02 2018-10-23 艾德克斯实验室公司 用于检测和诊断肾病和牙周病的方法和组合物
CN116930498A (zh) * 2023-08-29 2023-10-24 中国人民解放军军事科学院军事医学研究院 一种原发性肝细胞癌切除术后复发风险预测试剂盒及其应用

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090047694A1 (en) * 2007-08-17 2009-02-19 Shuber Anthony P Clinical Intervention Directed Diagnostic Methods
EP2527467A3 (en) * 2007-04-13 2013-03-20 Bristol-Myers Squibb Company Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
US20090029372A1 (en) * 2007-05-14 2009-01-29 Kobenhavns Universitet Adam12 as a biomarker for bladder cancer
US8431367B2 (en) 2007-09-14 2013-04-30 Predictive Biosciences Corporation Detection of nucleic acids and proteins
US20100267041A1 (en) * 2007-09-14 2010-10-21 Predictive Biosciences, Inc. Serial analysis of biomarkers for disease diagnosis
US7955822B2 (en) * 2007-09-14 2011-06-07 Predictive Biosciences Corp. Detection of nucleic acids and proteins
US20120053079A1 (en) * 2009-03-06 2012-03-01 University Of South Alabama Methods and compositions for the diagnosis, prognosis and treatment of cancer
JP5451552B2 (ja) * 2010-08-09 2014-03-26 オリンパス株式会社 顕微鏡システム、標本観察方法およびプログラム
EP2592421B1 (en) * 2011-11-14 2017-08-30 Universitätsklinikum Jena Diagnosis of sepsis and systemic inflammatory response syndrome
US20160130346A1 (en) * 2013-05-29 2016-05-12 Institut National De La Sante Et De La Recherche Medicale Kir3dl2 is a biomarker and a therapeutic target useful for respectively preventing and treating a subset of cutaneous and non-cutaneous peripheral t-cell lymphomas
JP6250351B2 (ja) * 2013-09-30 2017-12-20 シスメックス株式会社 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー
WO2018187311A1 (en) * 2017-04-03 2018-10-11 Biodetego Llc Biomarkers and methods of using same
GB201810571D0 (en) * 2018-06-27 2018-08-15 Cs Genetics Ltd Reagents and methods for the analysis of circulating microparticles
US20210325380A1 (en) * 2020-04-20 2021-10-21 EnLiSense, LLC Disease diagnostics using a multi-configurable sensing array

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
US6566101B1 (en) * 1997-06-16 2003-05-20 Anthony P. Shuber Primer extension methods for detecting nucleic acids
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
JP3771502B2 (ja) * 2002-02-14 2006-04-26 国立大学法人 新潟大学 精神分裂病により発現量が変化する遺伝子を規定する核酸を解析する方法
WO2004059293A2 (en) * 2002-12-24 2004-07-15 Biosite Incorporated Markers for differential diagnosis and methods of use thereof
US7666583B2 (en) * 2004-02-19 2010-02-23 Yale University Identification of cancer protein biomarkers using proteomic techniques
US20080280774A1 (en) * 2005-02-16 2008-11-13 Wyeth Methods and Systems for Diagnosis, Prognosis and Selection of Treatment of Leukemia
JP2008536480A (ja) * 2005-02-17 2008-09-11 ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド 癌の同定、評価、予防、および治療用組成物、キット、および方法、ならびに癌の治療法
BRPI0609302A2 (pt) * 2005-04-15 2011-10-11 Becton Dickinson Co métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse
US20070099239A1 (en) * 2005-06-24 2007-05-03 Raymond Tabibiazar Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease
US20090264306A1 (en) * 2005-10-27 2009-10-22 Curators Of The University Of Missouri Dna methylation biomarkers in lymphoid and hematopoietic malignancies
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
ES2606015T3 (es) * 2005-12-22 2017-03-17 Abbott Molecular Inc. Métodos y combinaciones de marcadores para la detección de la predisposición al cáncer de pulmón
US20070255113A1 (en) * 2006-05-01 2007-11-01 Grimes F R Methods and apparatus for identifying disease status using biomarkers
US20090047694A1 (en) * 2007-08-17 2009-02-19 Shuber Anthony P Clinical Intervention Directed Diagnostic Methods

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108700600A (zh) * 2016-03-02 2018-10-23 艾德克斯实验室公司 用于检测和诊断肾病和牙周病的方法和组合物
CN108700600B (zh) * 2016-03-02 2022-06-03 艾德克斯实验室公司 用于检测和诊断肾病和牙周病的方法和组合物
CN116930498A (zh) * 2023-08-29 2023-10-24 中国人民解放军军事科学院军事医学研究院 一种原发性肝细胞癌切除术后复发风险预测试剂盒及其应用
CN116930498B (zh) * 2023-08-29 2023-12-12 中国人民解放军军事科学院军事医学研究院 一种原发性肝细胞癌切除术后复发风险预测试剂盒及其应用

Also Published As

Publication number Publication date
WO2009036288A1 (en) 2009-03-19
CA2698859A1 (en) 2009-03-19
EP2198295A1 (en) 2010-06-23
EP2198295A4 (en) 2010-08-25
JP2010539490A (ja) 2010-12-16
US20090075266A1 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
CN101878426A (zh) 多个待测物诊断输出
US20090047694A1 (en) Clinical Intervention Directed Diagnostic Methods
CN113396332B (zh) 评价妊娠进展和早产流产以进行临床干预的方法及其应用
EP3230740B1 (en) Marker combinations for diagnosing infections and methods of use thereof
US11773446B2 (en) Methods for assessment of multiple sclerosis activity
US20110251099A1 (en) SERUM MARKERS PREDICTING CLINICAL RESPONSE TO ANTI-TNFa ANTIBODIES IN PATIENTS WITH ANKYLOSING SPONDYLITIS
US20120178100A1 (en) Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis
WO2015157557A1 (en) Methods of diagnosing pancreatic cancer and methods related thereto
JP2019512082A (ja) 早産のリスクを予測するためのツール
CN116287207B (zh) 生物标志物在诊断心血管相关疾病中的应用
US20170336409A1 (en) Biomarker signatures for lyme disease and methods of use thereof
EP2126562B1 (en) Clinical intervention directed diagnostic methods
Izbicka et al. Plasma biomarkers distinguish non-small cell lung cancer from asthma and differ in men and women
CN113302495B (zh) 膀胱癌的检测
US20220390466A1 (en) Biomarkers of early osteoarthritis
US10725038B2 (en) Biomarker signatures for lyme disease differentiation and methods of use thereof
US20160018413A1 (en) Methods of Prognosing Preeclampsia
EP3325972A1 (en) Biomarker combinations for prostate disease
EP3861349A1 (en) A method for differentially diagnosing in vitro a bipolar disorder and a major depressive disorder
KR102450582B1 (ko) 바이오마커의 추출방법, 췌장암 진단용 바이오마커 및 이를 이용한 췌장암의 진단 방법
HK1138376B (en) Clinical intervention directed diagnostic methods
Goel et al. Serum Biomarker Profile Explains Heterogenity in Patients With Takayasu Arteritis: An Exploratory Analysis
HK40062939A (en) Methods for evaluation of gestational progress and preterm abortion for clinical intervention and applications thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Shuber Anthony

Inventor after: Eugene Kiu

Inventor before: Shuber Anthony

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: SHUBER ANTHONY TO: SHUBER ANTHONY CHIU EUGENE

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20101103